Search Results 361-370 of 19495 for alzheimers
The apolipoprotein E, or APOE, gene is the strongest genetic risk factor for Alzheimer's disease, as most people who get the disease carry the gene. The ...
“While it is well accepted that age is the strongest risk factor for Alzheimer's, there is an enormous need to understand interacting factors that contribute to ...
A Study to Evaluate Intentional Technology Pairing for Caregivers of Patients with Alzheimer's Disease and Other Types of Dementia · Share · Facebook · Twitter.
For treatment of Alzheimer's disease: For oral dosage form (extended-release capsules):. Adults—At first, 7 milligrams (mg) once a day. Your doctor ...
Dominantly Inherited Alzheimer Network (DIAN) ... The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's ...
Research. Researchers at Mayo Clinic study Alzheimer's disease, mild cognitive impairment, and other conditions that affect memory and thinking skills.
Alzheimer's disease affects all people. Armed with $41 million in new federal funding, Mayo Clinic researchers and colleagues from 13 other institutions around ...
About this study. Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the ...
Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.